Literature DB >> 23978894

Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy.

Emily P Hyle, Paul E Sax, Rochelle P Walensky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23978894      PMCID: PMC3980729          DOI: 10.1001/jamainternmed.2013.9329

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

Review 1.  Life expectancy living with HIV: recent estimates and future implications.

Authors:  Fumiyo Nakagawa; Margaret May; Andrew Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

2.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

3.  Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Authors:  David B Hanna; Kate Buchacz; Kelly A Gebo; Nancy A Hessol; Michael A Horberg; Lisa P Jacobson; Gregory D Kirk; Mari M Kitahata; P Todd Korthuis; Richard D Moore; Sonia Napravnik; Pragna Patel; Michael J Silverberg; Timothy R Sterling; James H Willig; Bryan Lau; Keri N Althoff; Heidi M Crane; Ann C Collier; Hasina Samji; Jennifer E Thorne; M John Gill; Marina B Klein; Jeffrey N Martin; Benigno Rodriguez; Sean B Rourke; Stephen J Gange
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

4.  Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

Authors:  Howard B Gale; Steven R Gitterman; Heather J Hoffman; Fred M Gordin; Debra A Benator; Ann M Labriola; Virginia L Kan
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

  4 in total
  13 in total

1.  HIV Viral Load Monitoring Frequency and Risk of Treatment Failure among Immunologically Stable HIV-Infected Patients Prescribed Combination Antiretroviral Therapy.

Authors:  Benjamin Young; Rachel L D Hart; Kate Buchacz; Mia Scott; Frank Palella; John T Brooks
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-20

2.  Is CD4 monitoring needed among ugandan clients achieving a virologic and immunologic response to treatment?

Authors:  Steven J Reynolds; Joseph B Sempa; Agnes N Kiragga; Kevin Newell; Gertrude Nakigozi; Ronald Galiwango; Ron Gray; Thomas C Quinn; David Serwadda; Larry Chang
Journal:  AIDS Patient Care STDS       Date:  2014-10-07       Impact factor: 5.078

3.  CD4 measurement in a 54-year-old man with sustained HIV-1 viral suppression.

Authors:  Allan Yan; Jerome A Leis; Wayne L Gold
Journal:  CMAJ       Date:  2016-03-29       Impact factor: 8.262

4.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

5.  Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Authors:  Mary-Ann Davies; Nathan Ford; Helena Rabie; Geoffrey Fatti; Kathryn Stinson; Janet Giddy; Frank Tanser; Karl-Günter Technau; Shobna Sawry; Brian Eley; Robin Wood; Lynne M Mofenson; Olivia Keiser; Andrew Boulle
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

Review 6.  CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Nathan Ford; Kathryn Stinson; Howard Gale; Edward J Mills; Wendy Stevens; Mercedes Pérez González; Mercedes P González; Jessica Markby; Andrew Hill
Journal:  J Int AIDS Soc       Date:  2015-08-07       Impact factor: 5.396

7.  Derivation and validation of an accurate estimation of CD4 counts from the absolute lymphocyte count in virologically suppressed and immunologically reconstituted HIV infected adults.

Authors:  Barnaby Young; Oon Tek Ng; David Chien Lye; Yee Sin Leo
Journal:  BMC Infect Dis       Date:  2015-08-13       Impact factor: 3.090

8.  Reducing Viral Load Measurements to Once a Year in Patients on Stable, Virologically Suppressive Cart Regimen: Findings from the Australian HIV Observational Database.

Authors:  Mahshid Rafiee; Azar Kariminia; Stephen Wright; Graham Mills; Ian Woolley; Don Smith; David J Templeton; Matthew G Law; Kathy Petoumenos
Journal:  J AIDS Clin Res       Date:  2014-12

9.  Implementation and Operational Research: CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 Cells Per Cubic Millimeter Among Stable HIV-Infected Patients in New York City, 2007-2013.

Authors:  Julie E Myers; Qiang Xia; Lucia V Torian; Mary Irvine; Graham Harriman; Kent A Sepkowitz; Colin W Shepard
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

10.  Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.

Authors:  T B Leeme; M Mine; K Lechiile; F Mulenga; M Mosepele; T Mphoyakgosi; C Muthoga; J Ngidi; B Nkomo; D Ramaabya; M Tau; M W Tenforde; R Hayes; J N Jarvis
Journal:  HIV Med       Date:  2020-09-02       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.